<?xml version="1.0" encoding="UTF-8"?><rss version="2.0" xmlns:content="http://purl.org/rss/1.0/modules/content/"><channel><title>中康开思 | wechat-feeds</title><link>http://MzUyODM5NzU3Ng.favicon.privacyhide.com/favicon.ico</link><description>基于数据科学，提供高效便捷的健康产业数据情报，连接数据与决策。</description><managingEditor> (hellodword)</managingEditor><pubDate>Mon, 01 Feb 2021 16:48:22 +0800</pubDate><image><url>http://MzUyODM5NzU3Ng.favicon.privacyhide.com/favicon.ico</url><title>中康开思 | wechat-feeds</title><link>http://MzUyODM5NzU3Ng.favicon.privacyhide.com/favicon.ico</link><width>64</width><height>64</height></image><item><title>开拓药业新药受理号申报最多 | 药品审评进度周周看（1.25-1.31）</title><link>https://mp.weixin.qq.com/s/JizalgIrqrKK36xG274kig</link><description></description><content:encoded><![CDATA[开拓药业新药受理号申报最多 | 药品审评进度周周看（1.25-1.31）]]></content:encoded><pubDate>Mon, 01 Feb 2021 14:34:43 +0800</pubDate></item><item><title>辉瑞受理号申报最多 | 药品审评进度周周看（1.18-1.24）</title><link>https://mp.weixin.qq.com/s/0bxQoIJSb23Qour2G_kkAg</link><description></description><content:encoded><![CDATA[辉瑞受理号申报最多 | 药品审评进度周周看（1.18-1.24）]]></content:encoded><pubDate>Mon, 25 Jan 2021 16:06:01 +0800</pubDate></item><item><title>【开思系统数据更新】终端品类分析11月份数据更新上线！</title><link>https://mp.weixin.qq.com/s/Ds8x_8jdptYK-1s21WVK7g</link><description></description><content:encoded><![CDATA[【开思系统数据更新】终端品类分析11月份数据更新上线！]]></content:encoded><pubDate>Mon, 25 Jan 2021 16:06:01 +0800</pubDate></item><item><title>信立泰新药受理号申报最多 | 药品审评进度周周看（1.11-1.17）</title><link>https://mp.weixin.qq.com/s/3g63MgTAJzupEQaW_B_Q1Q</link><description></description><content:encoded><![CDATA[信立泰新药受理号申报最多 | 药品审评进度周周看（1.11-1.17）]]></content:encoded><pubDate>Mon, 18 Jan 2021 15:49:13 +0800</pubDate></item><item><title>酚酞片禁售！或将释放十亿级潜力增量市场！</title><link>https://mp.weixin.qq.com/s/X39d1A6GDRiRE4WfB3X8ow</link><description></description><content:encoded><![CDATA[酚酞片禁售！或将释放十亿级潜力增量市场！]]></content:encoded><pubDate>Mon, 18 Jan 2021 15:49:13 +0800</pubDate></item><item><title>中康CMH | 咽喉用药触底反弹！蓝芩、复方鱼腥草、冬凌草口服液驱动增长！</title><link>https://mp.weixin.qq.com/s/heZFwwx4QnC1oexto6f_7w</link><description></description><content:encoded><![CDATA[中康CMH | 咽喉用药触底反弹！蓝芩、复方鱼腥草、冬凌草口服液驱动增长！]]></content:encoded><pubDate>Mon, 18 Jan 2021 15:49:13 +0800</pubDate></item><item><title>安科生物新药受理号申报最多 | 药品审评进度周周看（1.4-1.10）</title><link>https://mp.weixin.qq.com/s/_O1AziadfSy8PoYTGkmymA</link><description></description><content:encoded><![CDATA[安科生物新药受理号申报最多 | 药品审评进度周周看（1.4-1.10）]]></content:encoded><pubDate>Mon, 11 Jan 2021 16:18:10 +0800</pubDate></item><item><title>中康CMH | 益生菌品类发展概况：百家争鸣，鏖战蓝海</title><link>https://mp.weixin.qq.com/s/mqfWIVgY_moUVNYf6UYwYQ</link><description></description><content:encoded><![CDATA[中康CMH | 益生菌品类发展概况：百家争鸣，鏖战蓝海]]></content:encoded><pubDate>Mon, 11 Jan 2021 16:18:10 +0800</pubDate></item><item><title>默沙东受理号申报最多 | 药品审评进度周周看（12.28-1.3）</title><link>https://mp.weixin.qq.com/s/pb3tofUoNHUYQjfY3LT9_Q</link><description></description><content:encoded><![CDATA[默沙东受理号申报最多 | 药品审评进度周周看（12.28-1.3）]]></content:encoded><pubDate>Mon, 04 Jan 2021 15:59:50 +0800</pubDate></item><item><title>【开思系统数据更新】终端品类分析10月份数据更新上线！</title><link>https://mp.weixin.qq.com/s/cemRbIo-6IpGrgxcGnoAVg</link><description></description><content:encoded><![CDATA[【开思系统数据更新】终端品类分析10月份数据更新上线！]]></content:encoded><pubDate>Mon, 04 Jan 2021 15:59:50 +0800</pubDate></item><item><title>贝达药业新药受理号申报最多 | 药品审评进度周周看（12.21-12.27）</title><link>https://mp.weixin.qq.com/s/cGXKR-cvN7fdf5guVd2ldg</link><description></description><content:encoded><![CDATA[贝达药业新药受理号申报最多 | 药品审评进度周周看（12.21-12.27）]]></content:encoded><pubDate>Mon, 04 Jan 2021 15:59:50 +0800</pubDate></item><item><title>受理号申报数量上升 | 药品审评进度周周看（12.14-12.20）</title><link>https://mp.weixin.qq.com/s/Ljg1TQ6I9YmzBQ5XljWRYQ</link><description></description><content:encoded><![CDATA[受理号申报数量上升 | 药品审评进度周周看（12.14-12.20）]]></content:encoded><pubDate>Mon, 21 Dec 2020 16:14:58 +0800</pubDate></item><item><title>国产药品申报比例上升 | 药品审评进度周周看（12.7-12.13）</title><link>https://mp.weixin.qq.com/s/XOB2pqv-XPKAhi4YA11F3g</link><description></description><content:encoded><![CDATA[国产药品申报比例上升 | 药品审评进度周周看（12.7-12.13）]]></content:encoded><pubDate>Mon, 14 Dec 2020 16:07:36 +0800</pubDate></item><item><title>施维雅受理号申报最多 | 药品审评进度周周看（11.30-12.6）</title><link>https://mp.weixin.qq.com/s/SV8pUgGrLzh17YM6ciAnKg</link><description></description><content:encoded><![CDATA[施维雅受理号申报最多 | 药品审评进度周周看（11.30-12.6）]]></content:encoded><pubDate>Mon, 07 Dec 2020 12:11:10 +0800</pubDate></item><item><title>轩竹生物新药受理号申报最多 | 药品审评进度周周看（11.23-11.28）</title><link>https://mp.weixin.qq.com/s/mlb9SEMvx30iulFlxUFSug</link><description></description><content:encoded><![CDATA[轩竹生物新药受理号申报最多 | 药品审评进度周周看（11.23-11.28）]]></content:encoded><pubDate>Tue, 01 Dec 2020 14:49:20 +0800</pubDate></item><item><title>【开思系统数据更新】2020年第三季度铺货率数据更新上线！</title><link>https://mp.weixin.qq.com/s/ZUXjb9ORwoXp_t4vUZlhPQ</link><description></description><content:encoded><![CDATA[【开思系统数据更新】2020年第三季度铺货率数据更新上线！]]></content:encoded><pubDate>Tue, 01 Dec 2020 14:49:20 +0800</pubDate></item><item><title>辉瑞受理号申报最多 | 药品审评进度周周看（11.16-11.21）</title><link>https://mp.weixin.qq.com/s/z5SN6z6pOzVQyWXpBtEzaQ</link><description></description><content:encoded><![CDATA[辉瑞受理号申报最多 | 药品审评进度周周看（11.16-11.21）]]></content:encoded><pubDate>Mon, 23 Nov 2020 11:58:23 +0800</pubDate></item></channel></rss>